T Cell News and Research

Latest T Cell News and Research

Discovery of major genetic cause of colorectal cancer

About one-third of colorectal cancers are inherited, but the genetic cause of most of these cancers is unknown. The genes linked to colorectal cancer account for less than 5 percent of all cases.

14 Aug 2008

New model for studying the genetics of Angelman syndrome

A model for studying the genetics of Angelman syndrome, a neurological disorder that causes mental retardation and other symptoms in one out of 15,000 births, has been developed by biologists at The University of Texas at Austin.

14 Aug 2008

Researchers find Leishmaniasis parasites evade death by exploiting the immune response to sand fly bites

Cutaneous leishmaniasis, a disease characterized by painful skin ulcers, occurs when the parasite Leishmania major, or a related species, is transmitted to a mammalian host by the bite of an infected sand fly.

14 Aug 2008

Universal gene signaling mechanism identified by UB molecular researchers

A novel gene signaling mechanism that controls whether a stem cell develops into its destined tissue or fails to differentiate and becomes cancer has been identified by researchers in the multi-laboratory Molecular and Structural Neurobiology and Gene Therapy Program based at the University at Buffalo.

14 Aug 2008

Researchers show how DNA repairs may reshape the genome

Researchers at Duke University Medical Center and at the National Institute of Environmental Health Sciences (NIEHS) have shown how broken sections of chromosomes can recombine to change genomes and spawn new species.

13 Aug 2008

New understanding of how white blood cell eosiniphils fights infection

U.S. and Swiss scientists have made a breakthrough in understanding how a type of white blood cell called the eosinophil may help the body to fight bacterial infections in the digestive tract, according to research published online this week in Nature Medicine

13 Aug 2008

St. Jude Medical receives approval of first extended-life primary cell neurostimulator for treatment of chronic pain

St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of EonC, the first extended-life primary cell (non-rechargeable) neurostimulator for the treatment of chronic pain.

13 Aug 2008

Molecular switch provides insights into a form of altered brain activity occurring in schizophrenia

People with schizophrenia have an alteration in a pattern of brain electrical activity associated with learning and memory. Now, researchers from the National Institutes of Health and Sweden's Karolinska Institute have identified in mouse brain tissue a molecular switch that, when thrown, increases the strength of this electrical pattern. The researchers found that adding the brain chemical Neuregulin-1 to the brain tissue boosted the electrical signals that the tissue generated.

13 Aug 2008

A snooze button for the circadian clock

We may use the snooze button to fine-tune our sleep cycles, but our cells have a far more meticulous and refined system. Humans, and most other organisms, have 24-hour rhythms that are regulated by a precise molecular clock that ticks inside every cell.

13 Aug 2008

Experimental chemo shows promise in treating advanced non-small cell lung cancer

A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.

12 Aug 2008

Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs

AIDS experts at Johns Hopkins say they have compelling evidence that some people with HIV who for years and even decades show extremely low levels of the virus in their blood never progress to full-blown AIDS and remain symptom free even without treatment, probably do so because of the strength of their immune systems, not any defects in the strain of HIV that infected them in the first place.

12 Aug 2008

Virginia Hospital Center to launch $14 million new hospital information system

Virginia Hospital Center will launch a $14 million new Hospital Information System (HIS) in 2009 that will utilize advanced information technologies (IT) to create efficiencies and orchestrate clinical best practices. The Hospital signed an agreement with Siemens Medical Solutions and will implement its powerful workflow-engineered health information solution, Soarian.

12 Aug 2008

Medulloblastoma in children - two studies find clues to treatment

Medulloblastoma is one of the most common and most malignant brain tumours among children and teenagers. These tumours grow very rapidly, and fifty percent of patients in the long term die from the condition. The details of the processes that lead to the growth of these tumours have remained unknown until now.

12 Aug 2008

Ruthenium used to sucker punch cancer

Chemists are pulling cancer onto a sucker punch by getting infected cells to drop their guard - according to research published today. They are using the metal ruthenium as a catalyst to a cancer-busting reaction which calls up an old cellular enemy - oxidants - as an ally.

12 Aug 2008

NCI awards Wilmot scientists $1.6 million to study lymphoma treatments

The National Cancer Institute has tapped a team of scientists at the James P. Wilmot Cancer Center to lead a $1.6 million in research program to improve lymphoma treatment, an area of excellence in research and care for the University of Rochester Medical Center.

12 Aug 2008

MicroRNAs help control blood-vessel development

The development and repair of heart tissue and blood vessels is intimately tied to a tiny piece of ribonucleic acid (RNA) that is found nowhere else in the body, researchers at UT Southwestern Medical Center have found.

12 Aug 2008

Australian researchers reveal how cancers become more aggressive

A team of Australian scientists have discovered how some cancers are able to mutate into more aggressive and potentially fatal cancers in the human body.

11 Aug 2008

Researchers identify molecular mechanism underlying a genetic brain malformation called holoprosencephaly

St. Jude Children's Research Hospital scientists have identified one of the molecular mechanisms underlying the genetic brain malformation called holoprosencephaly (HPE).

11 Aug 2008

Scientists identify microRNA that controls blood vessel development - therapeutic target for a number of diseases

Scientists from the Gladstone Institute of Cardiovascular Disease (GICD) and UCSF have identified a key regulatory factor that controls development of the human vascular system, the extensive network of arteries, veins, and capillaries that allow blood to reach all tissues and organs.

11 Aug 2008

Newly discovered molecular switch creates new path to study birth defects and cancer

Researchers have discovered a central molecular switch in fruit fly embryos that opens new avenues for studying the causes of birth defects and cancer in humans.

11 Aug 2008

T Cell News and Research

Latest T Cell News and Research

Discovery of major genetic cause of colorectal cancer

New model for studying the genetics of Angelman syndrome

Researchers find Leishmaniasis parasites evade death by exploiting the immune response to sand fly bites

Universal gene signaling mechanism identified by UB molecular researchers

Researchers show how DNA repairs may reshape the genome

New understanding of how white blood cell eosiniphils fights infection

St. Jude Medical receives approval of first extended-life primary cell neurostimulator for treatment of chronic pain

Molecular switch provides insights into a form of altered brain activity occurring in schizophrenia

A snooze button for the circadian clock

Experimental chemo shows promise in treating advanced non-small cell lung cancer

Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs

Virginia Hospital Center to launch $14 million new hospital information system

Medulloblastoma in children - two studies find clues to treatment

Ruthenium used to sucker punch cancer

NCI awards Wilmot scientists $1.6 million to study lymphoma treatments

MicroRNAs help control blood-vessel development

Australian researchers reveal how cancers become more aggressive

Researchers identify molecular mechanism underlying a genetic brain malformation called holoprosencephaly

Scientists identify microRNA that controls blood vessel development - therapeutic target for a number of diseases

Newly discovered molecular switch creates new path to study birth defects and cancer

Immunology eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in